Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	methyl-CpG binding	MBD3L5 ZBTB33 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	1.74e-07	31	164	6	GO:0008327
GeneOntologyMolecularFunction	protein serine kinase activity	CDC42BPA CDK12 SNRK WNK1 PIKFYVE TTBK2 SIK2 MASTL MAP3K9 TNK2 MAP2K7	2.12e-04	363	164	11	GO:0106310
GeneOntologyBiologicalProcess	DNA methylation-dependent constitutive heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B BAZ2A ATF7IP	5.51e-08	44	165	7	GO:0006346
GeneOntologyBiologicalProcess	facultative heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B BAZ2A ATF7IP	2.71e-07	55	165	7	GO:0140718
GeneOntologyBiologicalProcess	heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B BAZ2A ATF7IP DOT1L UTY	6.73e-06	163	165	9	GO:0031507
GeneOntologyBiologicalProcess	negative regulation of gene expression, epigenetic	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B BAZ2A ATF7IP DOT1L UTY	3.87e-05	203	165	9	GO:0045814
Domain	SEA	MUC16 MUC13 MUC17 MUC3A IMPG2	8.67e-08	14	162	5	SM00200
Domain	MeCpG-bd_2/3_C_dom	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.87e-07	7	162	4	IPR025884
Domain	MBD2/MBD3_p55-bd	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.87e-07	7	162	4	IPR032343
Domain	MBDa	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.87e-07	7	162	4	PF16564
Domain	MBD_C	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.87e-07	7	162	4	PF14048
Domain	SEA	MUC16 MUC13 MUC17 MUC3A IMPG2	1.37e-06	23	162	5	PS50024
Domain	SEA_dom	MUC16 MUC13 MUC17 MUC3A IMPG2	1.37e-06	23	162	5	IPR000082
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	2.55e-06	4	162	3	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	2.55e-06	4	162	3	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	2.55e-06	4	162	3	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	2.55e-06	4	162	3	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	2.55e-06	4	162	3	IPR015753
Domain	EGF_3	FAT4 MUC13 CELSR1 FAT2 HEG1 HMCN2 MUC17 ASTN1 MUC3A OTOG IMPG2	6.68e-06	235	162	11	PS50026
Domain	Laminin_G	FAT4 COL9A1 COL24A1 CELSR1 FAT2 CSPG4	1.08e-05	58	162	6	IPR001791
Domain	EGF-like_dom	FAT4 MUC13 CELSR1 FAT2 HEG1 HMCN2 MUC17 ASTN1 MUC3A OTOG IMPG2	1.15e-05	249	162	11	IPR000742
Domain	LAM_G_DOMAIN	FAT4 COL24A1 CELSR1 FAT2 CSPG4	1.84e-05	38	162	5	PS50025
Domain	Laminin_G_2	FAT4 COL24A1 CELSR1 FAT2 CSPG4	2.38e-05	40	162	5	PF02210
Domain	SEA	MUC16 MUC13 MUC17 IMPG2	3.53e-05	22	162	4	PF01390
Domain	EGF_1	FAT4 MUC13 CELSR1 FAT2 HEG1 HMCN2 MUC17 ASTN1 MUC3A IMPG2	7.93e-05	255	162	10	PS00022
Domain	EGF-like_CS	FAT4 MUC13 CELSR1 FAT2 HEG1 HMCN2 MUC17 ASTN1 MUC3A IMPG2	9.62e-05	261	162	10	IPR013032
Domain	EGF_2	FAT4 MUC13 CELSR1 FAT2 HEG1 HMCN2 MUC17 ASTN1 MUC3A IMPG2	1.09e-04	265	162	10	PS01186
Domain	-	FAT4 COL9A1 COL24A1 CELSR1 FAT2 CSPG4	1.78e-04	95	162	6	2.60.120.200
Domain	-	MUC16 MUC17 IMPG2	2.70e-04	15	162	3	3.30.70.960
Domain	LamG	FAT4 CELSR1 FAT2 CSPG4	5.65e-04	44	162	4	SM00282
Domain	LRR_8	LRRC37A3 MFHAS1 LRRC37A2 LRCH3 LRRC37A PHLPP2 LGI1	7.40e-04	171	162	7	PF13855
Domain	LRR_TYP	LRRC37A3 MFHAS1 LRRC37A2 LRCH3 LRRC37A PHLPP2 LGI1	9.07e-04	177	162	7	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRRC37A3 MFHAS1 LRRC37A2 LRCH3 LRRC37A PHLPP2 LGI1	9.07e-04	177	162	7	IPR003591
Domain	EGF	FAT4 MUC13 CELSR1 FAT2 HEG1 MUC17 ASTN1 MUC3A	1.05e-03	235	162	8	SM00181
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC13 MUC17 MUC3A MUC6	1.53e-07	16	118	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC13 MUC17 MUC3A MUC6	2.15e-07	17	118	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC13 MUC17 MUC3A MUC6	1.13e-06	23	118	5	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC13 MUC17 MUC3A MUC6	2.16e-06	26	118	5	M27483
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MPDU1 MUC16 MUC13 B4GALT1 MUC17 CSPG4 ALG8 MUC3A MUC6	3.09e-06	143	118	9	M27275
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC13 MUC17 MUC6	2.50e-05	21	118	4	MM15706
Pathway	REACTOME_DISEASES_OF_METABOLISM	CYP1B1 MPDU1 MUC16 MUC13 B4GALT1 MUC17 CSPG4 ALG8 MUC3A MUC6	4.68e-05	250	118	10	M27554
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC13 MUC17 MUC3A MUC6	1.67e-04	62	118	5	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC13 MUC17 MUC3A MUC6	2.58e-04	68	118	5	M27303
Pubmed	MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	1.67e-11	6	172	5	12504854
Pubmed	Haploid male germ cell- and oocyte-specific Mbd3l1 and Mbd3l2 genes are dispensable for early development, fertility, and zygotic DNA demethylation in the mouse.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	1.67e-11	6	172	5	18942147
Pubmed	MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	8.05e-09	15	172	5	15701600
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC13 MUC17 MUC3A MUC6	2.27e-08	18	172	5	18834073
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ATMIN MPDU1 POU2F1 RICTOR TSC22D2 FCHO2 WNK1 VIRMA MRPL35 USP14 CNNM3 CRACD SETD2 PRDM10 LLGL2 GTF2I ARHGEF7 SCAPER ALG8 MAML2 MAP2K7 NIPBL FBXW7	1.86e-07	1327	172	23	32694731
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	4.74e-07	4	172	3	22419166
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATMIN ARHGEF12 GRB10 FHIP2A VIRMA UNC5A CRACD BAZ2A NAV1 RIPOR1 ADGRL3 SON	9.87e-07	407	172	12	12693553
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CLIP2 PPFIBP1 PTPN23 RICTOR WNK1 PIKFYVE SETD2 KRBA1 FAT2 USF3 SBF2 SCAPER LNPK	1.20e-06	493	172	13	15368895
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DMTF1 ACACB TSC22D2 WNK1 USF3 SAP30BP TNK2 MAML2 SAP130 ADGRL3 CRTC2 SON	1.75e-06	430	172	12	35044719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ATMIN ARSJ CDC42BPA MFHAS1 CDK12 GRB10 WNK1 PIKFYVE DIP2A CELSR1 HEG1 LLGL2 SBF2 CSPG4 IFRD2 NAV1 TNK2 RIPOR1 DOT1L	2.65e-06	1105	172	19	35748872
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CDK12 GRB10 FCHO2 WNK1 DENND4C CHMP7 GTF2I GMEB1 MASTL ELF1 NIPBL SON	8.60e-06	503	172	12	16964243
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	1.39e-05	10	172	3	23064749
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	BCL9L ACACB PPFIBP1 KIAA1549 RICTOR WNK1 DENND4C LRCH3 NAV1 CEP295 CRTC2	1.51e-05	446	172	11	24255178
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATMIN EP400P1 CDC42BPA GRB10 ZNF385B LRCH3 B4GALT1 DNAH1 USP14 USF3 GTF2I EFNB2 TECPR2 SBF2 NAV1 TNK2 RIPOR1 TRMT13 PCDH1 SAP130 RECK	1.61e-05	1489	172	21	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CYP1B1 BCL9L CDC42BPA CDK12 PPFIBP1 ARHGEF12 RICTOR DHX33 VIRMA LRCH3 TRIM33 CRACD SETD2 CELSR1 BAZ2A SUPT7L IFRD2 SAP30BP NIPBL DNASE1L1 SON	1.74e-05	1497	172	21	31527615
Pubmed	Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.	SIGLEC7 CD33	2.43e-05	2	172	2	18331725
Pubmed	Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.	SIK2 FBXW7	2.43e-05	2	172	2	32437091
Pubmed	Partial monosomy 9p (9p22.2-->pter) and partial trisomy 18q (18q21.32-->qter) in a female infant with anorectal malformations.	PIGN FREM1	2.43e-05	2	172	2	22876578
Pubmed	Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors.	SIGLEC7 CD33	2.43e-05	2	172	2	11774609
Pubmed	KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.	VIRMA MUC3A	2.43e-05	2	172	2	33249400
Pubmed	Pathogenic variations in MAML2 and MAMLD1 contribute to congenital hypothyroidism due to dyshormonogenesis by regulating the Notch signalling pathway.	MAMLD1 MAML2	2.43e-05	2	172	2	36898841
Pubmed	NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury.	PTPRZ1 CSPG4	2.43e-05	2	172	2	19604403
Pubmed	SnoN suppresses TGF-β-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1γ-dependent manner.	SKIL TRIM33	2.43e-05	2	172	2	27430247
Pubmed	Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells.	SIGLEC7 CD33	2.43e-05	2	172	2	10611343
Pubmed	Pax6 interactions with chromatin and identification of its novel direct target genes in lens and forebrain.	FAT4 EFNB2 NAV1	2.53e-05	12	172	3	23342162
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDC42BPA PPFIBP1 GRB10 RICTOR RFX7 WNK1 VIRMA DENND4C SRGAP1 SIK2 MAP3K9 NAV1 MAP2K7 CRTC2 OTOG	2.71e-05	861	172	15	36931259
Pubmed	A human MAP kinase interactome.	CDC42BPA CLIP2 PTPN23 WNK1 FAM13B USF3 ARHGEF7 ATF7IP NAV1 TNK2 BICRAL	3.32e-05	486	172	11	20936779
Pubmed	A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.	POU2F1 ATF7IP ELF1	4.16e-05	14	172	3	10976766
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	EP400P1 ZBTB33 KIAA1549 RICTOR SKIL TRIM33 SETD2 HMCN2 BAZ2A SUPT7L SAP30BP SCAPER CEP295 BICRAL MAP2K7 SAP130 SON	4.24e-05	1116	172	17	31753913
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	KIAA1549 GRB10 HSPA12A SCAPER NAV1 BICRAL	4.82e-05	130	172	6	12421765
Pubmed	SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis.	SKIL EFNB2 HEY2	5.18e-05	15	172	3	24019535
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	CDK12 POU2F1 GTF2I SAP130 NIPBL	5.93e-05	83	172	5	28794006
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	GRB10 APBA3 SNRK RICTOR FCHO2 FHIP2A WNK1 DENND4C CHMP7 TRIM33 SETD2 SBF2 SIK2 RIPOR1 MAP2K7 CRTC2	6.26e-05	1038	172	16	26673895
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZBTB33 ACACB CDK12 PTPN23 WNK1 USP14 CRACD SETD2 GTF2I BAZ2A ATF7IP SAP30BP MASTL NIPBL SON	6.79e-05	934	172	15	33916271
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC17 MUC3A	7.27e-05	3	172	2	10512748
Pubmed	Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study.	CELSR1 LLGL2	7.27e-05	3	172	2	19403135
Pubmed	SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.	SIK2 PHLPP2	7.27e-05	3	172	2	33128264
Pubmed	Significance of YAP1-MAML2 rearrangement and GTF2I mutation in the diagnosis and differential diagnosis of metaplastic thymoma.	GTF2I MAML2	7.27e-05	3	172	2	37489594
Pubmed	SIK2 is critical in the regulation of lipid homeostasis and adipogenesis in vivo.	SIK2 CRTC2	7.27e-05	3	172	2	24898145
Pubmed	PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.	SKIL TRIM33	7.27e-05	3	172	2	32770107
Pubmed	Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.	RICTOR FBXW7	7.27e-05	3	172	2	22285861
Pubmed	The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.	CLIP2 GTF2I	7.27e-05	3	172	2	22608712
Pubmed	Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.	HNF1A POU2F1	7.27e-05	3	172	2	10779377
Pubmed	Immunoglobulin genes of different subgroups are interdigitated within the VK locus.	IGKV3D-11 IGKV3-11	7.27e-05	3	172	2	6440122
Pubmed	Genome-scale RNAi screen for host factors required for HIV replication.	ACACB WNK1 PRDM10 HMCN2 SBF2 IFRD2 MAP3K9 SLC24A1 UTY	8.43e-05	361	172	9	18976975
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FAT4 ACACB LRRC37A3 MPDU1 MUC16 VIRMA IL1RAPL1 TTBK2 SUPT7L CEP295 NIPBL UTY	8.64e-05	638	172	12	31182584
Pubmed	A germline-specific class of small RNAs binds mammalian Piwi proteins.	COL9A1 LRRC37A2 POU2F1 SRR EYA3 TTBK2 SBF2 TNK2 DOT1L SON	8.85e-05	450	172	10	16751776
Pubmed	Human transcription factor protein interaction networks.	BCL9L HNF1A ZBTB33 CDC42BPA ACACB POU2F1 PROSER1 EYA3 RFX7 TRIM33 GTF2I ATF7IP SUPT7L GMEB1 ELF1 DOT1L SAP130 NIPBL FBXW7	9.13e-05	1429	172	19	35140242
Pubmed	Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice.	WNK1 EFNB2 HEY2	9.18e-05	18	172	3	19644017
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SFXN4 RC3H2 CDK12 PPFIBP1 RICTOR FHIP2A PRSS3P2 DIP2A LLGL2 ARHGEF7 SIK2 CRTC2	1.03e-04	650	172	12	38777146
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CLIP2 CDK12 PPFIBP1 PTPN23 SNRK WNK1 SIK2	1.37e-04	225	172	7	12168954
Pubmed	Endosomal phosphoinositides and human diseases.	PIKFYVE SBF2	1.45e-04	4	172	2	18429927
Pubmed	The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.	CELSR1 ADGRL3	1.45e-04	4	172	2	37224017
Pubmed	mRNA 5' region sequence incompleteness: a potential source of systematic errors in translation initiation codon assignment in human mRNAs.	DIP2A SON	1.45e-04	4	172	2	14637006
Pubmed	Mouse neuron navigator 1, a novel microtubule-associated protein involved in neuronal migration.	CLIP2 NAV1	1.45e-04	4	172	2	15797708
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	DENND4C GTF2I SBF2 SIK2 NAV1 SON FBXW7	1.65e-04	232	172	7	25515538
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PPFIBP1 CRACD PRDM10 HEG1 NAV1	1.65e-04	103	172	5	10574462
Pubmed	A census of human transcription factors: function, expression and evolution.	DMTF1 RC3H2 HNF1A ZBTB33 KIAA1549 POU2F1 TSC22D2 RFX7 SKIL USF3 DMRT2 GMEB1 HEY2 ELF1	1.82e-04	908	172	14	19274049
Pubmed	Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.	CSPG4 TNK2	2.41e-04	5	172	2	10587647
Pubmed	The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytes.	SIK2 CRTC2	2.41e-04	5	172	2	22462548
Pubmed	Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes.	SIGLEC7 CD33	2.41e-04	5	172	2	11943481
Pubmed	Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst.	SIGLEC7 CD33	2.41e-04	5	172	2	24227736
Pubmed	Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes.	SIK2 CRTC2	2.41e-04	5	172	2	19351809
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACB PPFIBP1 RICTOR FCHO2 LRCH3 CNNM3 HSPA12A LLGL2 EFNB2	2.66e-04	421	172	9	36976175
Pubmed	The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs.	MAMLD1 HEY2 MAML2	2.84e-04	26	172	3	24391519
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	BCL9L CDK12 PROSER1 EYA3 TRIM33 GTF2I ATF7IP SAP30BP NIPBL	2.85e-04	425	172	9	24999758
Pubmed	TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.	SKIL TRIM33	3.60e-04	6	172	2	25059663
Pubmed	The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.	RICTOR FBXW7	3.60e-04	6	172	2	30865892
Pubmed	14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).	SIK2 CRTC2	3.60e-04	6	172	2	29211348
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC6	3.60e-04	6	172	2	19110483
Pubmed	Formation and maturation of the native cerebral collateral circulation.	EFNB2 CSPG4	3.60e-04	6	172	2	20346953
Pubmed	Mouse immunoglobulin chains. Pattern of sequence variation among kappa chains with limited sequence differences.	IGKV3D-20 IGKV3D-11	3.60e-04	6	172	2	4691517
Pubmed	Primary structures of N-terminal extra peptide segments linked to the variable and constant regions of immunoglobulin light chain precursors: implications on the organization and controlled expression of immunoglobulin genes.	IGKV3D-20 IGKV3D-11	3.60e-04	6	172	2	98179
Pubmed	Mechanisms of antibody diversity: multiple genes encode structurally related mouse kappa variable regions.	IGKV3D-20 IGKV3D-11	3.60e-04	6	172	2	99744
Pubmed	PtdIns5P regulation through evolution: roles in membrane trafficking?	PIKFYVE SBF2	3.60e-04	6	172	2	18774718
Pubmed	ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex.	ZBTB33 ATF7IP	3.60e-04	6	172	2	27732843
Pubmed	Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.	RICTOR FBXW7	3.60e-04	6	172	2	25897075
Pubmed	Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors.	BAZ2A MAP3K9 DOT1L	3.95e-04	29	172	3	24105743
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L ZBTB33 SKIL TRIM33 SUPT7L SAP130 NIPBL	3.96e-04	268	172	7	33640491
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	TRIM33 GTF2I ATF7IP SUPT7L GMEB1	4.06e-04	125	172	5	32891193
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZBTB33 CDK12 PTPN23 USP14 SETD2 GTF2I BAZ2A SAP30BP DOT1L SAP130	4.34e-04	549	172	10	38280479
Pubmed	14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK.	SNRK SIK2 CRTC2	4.37e-04	30	172	3	16306228
Pubmed	Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.	ZBTB33 GTF2I BAZ2A SAP30BP	4.57e-04	72	172	4	31248990
Pubmed	mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.	SIGLEC7 CD33	5.02e-04	7	172	2	11171044
Pubmed	Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2.	RC3H2 FBXW7	5.02e-04	7	172	2	29695787
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT4 FAT2	5.02e-04	7	172	2	16059920
Pubmed	IL-1β-activated mTORC2 promotes accumulation of IFN-γ+ γδ T cells by upregulating CXCR3 to restrict hepatic fibrosis.	RICTOR CRTC2	5.02e-04	7	172	2	35361750
Pubmed	The 3' part of the immunoglobulin kappa locus of the mouse.	IGKV3D-20 IGKV3D-11	5.02e-04	7	172	2	9603450
Pubmed	Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice.	CSPG4 RECK	5.02e-04	7	172	2	20691046
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CDK12 POU2F1 RICTOR RFX7 VIRMA SETD2 GTF2I BAZ2A ELF1 RIPOR1 NIPBL SON	5.03e-04	774	172	12	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FAT4 ZBTB33 CDC42BPA ACACB PPFIBP1 MUC16 RICTOR TRIM33 CNNM3 GTF2I EFNB2 ATF7IP	5.20e-04	777	172	12	35844135
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	CDC42BPA PPFIBP1 KIAA1549 RICTOR FCHO2 CNNM3 LLGL2 CSPG4 NAV1 PCDH1	5.72e-04	569	172	10	30639242
Pubmed	Mind bomb 1 is essential for generating functional Notch ligands to activate Notch.	EFNB2 HEY2 MAML2	5.81e-04	33	172	3	16000382
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	HCN1 ARHGEF12 POU2F1 TSC22D2 FHIP2A DENND4C LRCH3 TTBK2 PTPRZ1 SARDH HYDIN	6.53e-04	686	172	11	29987050
Pubmed	The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector.	SIK2 CRTC2	6.68e-04	8	172	2	15454081
Pubmed	Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity.	RICTOR CRTC2	6.68e-04	8	172	2	17043309
Pubmed	An extracellular-matrix-specific GEF-GAP interaction regulates Rho GTPase crosstalk for 3D collagen migration.	ARHGEF7 SRGAP1	6.68e-04	8	172	2	25150978
Pubmed	The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation.	DHX33 TRIM33	6.68e-04	8	172	2	25172487
Pubmed	Ubiquitylation of the ER-Shaping Protein Lunapark via the CRL3KLHL12 Ubiquitin Ligase Complex.	RICTOR LNPK	6.68e-04	8	172	2	32433973
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	DMTF1 HNF1A ZBTB33 POU2F1 SKIL KRBA1 GTF2I BAZ2A SCAPER GMEB1 ELF1 UTY	7.32e-04	808	172	12	20412781
Interaction	YWHAG interactions	RC3H2 HNF1A ZBTB33 CDC42BPA CDK12 PPFIBP1 GRB10 TNS2 RICTOR CNTLN RFX7 WNK1 VIRMA FAM13B DENND4C LRCH3 CCNF CRACD ARHGEF7 SRGAP1 SIK2 MAP3K9 NAV1 TNK2 CRTC2 OTOG SON FBXW7	1.19e-06	1248	166	28	int:YWHAG
Interaction	YWHAE interactions	RC3H2 HNF1A ZBTB33 CDC42BPA CDK12 PPFIBP1 GRB10 TNS2 RICTOR CNTLN WNK1 VIRMA FAM13B DENND4C LRCH3 TMEM11 CCNF CRACD ARHGEF7 SRGAP1 SIK2 MAP3K9 NAV1 DOT1L SAP130 CRTC2 OTOG FBXW7	1.35e-06	1256	166	28	int:YWHAE
Interaction	YWHAB interactions	RC3H2 HNF1A CDC42BPA PPFIBP1 TNS2 RICTOR CNTLN RFX7 WNK1 VIRMA DENND4C CCNF TRIM33 ARHGEF7 SRGAP1 SIK2 MAP3K9 NAV1 DOT1L SAP130 CRTC2 OTOG SON FBXW7	3.06e-06	1014	166	24	int:YWHAB
Interaction	TLE3 interactions	BCL9L CDK12 PROSER1 EYA3 VIRMA CCNF SETD2 MASTL DOT1L SAP130 NIPBL CRTC2 SON	1.49e-05	376	166	13	int:TLE3
Cytoband	19p13.2	MBD3L5 PRR36 MBD3L2 MUC16 MBD3L3 MBD3L4 MBD3L2B	2.73e-05	229	172	7	19p13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	MBD3L5 PRR36 MBD3L2 CAPS MUC16 APBA3 MBD3L3 MBD3L4 MBD3L2B DOT1L MAP2K7	2.27e-04	797	172	11	chr19p13
GeneFamily	CD molecules\|Mucins	MUC16 MUC13 MUC17 MUC3A MUC6	8.88e-08	21	100	5	648
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	DMTF1 CDC42BPA ACACB FCHO2 FHIP2A WNK1 PRDM10 BAZ2A SCAPER NAV1 CRTC2 SON	1.10e-09	166	172	12	M6826
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	DMTF1 CLIP2 MFHAS1 GRB10 POU2F1 TSC22D2 SKIL DENND4C TRIM33 TTBK2 SETD2 PRDM10 BAZ2A ARHGEF7 ATF7IP GMEB1 MAP3K9 ELF1 RIPOR1 NIPBL	5.10e-07	822	172	20	M6782
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	BCL9L CDK12 TSC22D2 SETD2 USF3 ARHGEF7 MAP2K7 NIPBL CRTC2	5.29e-06	192	172	9	M8272
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	COL9A1 ACACB CLIP2 PRR36 MFSD6 CEP57L1 MAMLD1 ARHGEF12 POU2F1 ZNF385B CNTLN FCHO2 WNK1 COL24A1 KRBA1 SAP30BP NAV1 ALG8 ASTN1 CEP295 SARDH MUC6 NIPBL	2.57e-06	989	165	23	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ZBTB33 CEP57L1 MAMLD1 ARHGEF12 POU2F1 CNTLN WNK1 TRIM33 DIP2A ARHGEF7 ALG8 ASTN1 CEP295 SARDH NIPBL SON	3.33e-05	629	165	16	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 ARHGEF12 SNRK FAM13B HEG1 TNK2 NIPBL ADGRL3 SON	8.46e-08	200	171	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 COL9A1 FREM1 DNAH1 COL24A1 HYDIN ADGRL3 OTOG	5.85e-07	184	171	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 COL9A1 FREM1 DNAH1 COL24A1 HYDIN ADGRL3 OTOG	5.85e-07	184	171	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 COL9A1 FREM1 DNAH1 COL24A1 HYDIN ADGRL3 OTOG	5.85e-07	184	171	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL9A1 PI16 MAMLD1 F5 CRACD HEG1 EFNB2 NAV1	7.45e-07	190	171	8	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 COL9A1 PI16 MAMLD1 F5 HEG1 EFNB2 NAV1	7.75e-07	191	171	8	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZBTB33 POU2F1 DENND4C TRIM33 USF3 BAZ2A SBF2 SON	8.38e-07	193	171	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	RC3H2 POU2F1 RICTOR RFX7 TRIM33 ATF7IP MAML2	9.32e-07	135	171	7	b128596653a5e3b64ed7f657bbfeda35438e2e48
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL9A1 HCN1 FREM1 COL24A1 PTPRZ1 ASTN1 HYDIN	2.90e-06	160	171	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL9A1 HCN1 FREM1 COL24A1 PTPRZ1 ASTN1 HYDIN	2.90e-06	160	171	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	PTPN23 POU2F1 SETD2 USF3 ATF7IP SON IMPG2	3.70e-06	166	171	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	metastatic_Brain-Endothelial_cells-Stalk-like_ECs\|metastatic_Brain / Location, Cell class and cell subclass	PI16 ITGA10 GRB10 EYA3 KRBA1 HEG1 EFNB2	7.53e-06	185	171	7	ad52970e88e8947ef256095bd4b40229b912d58a
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HCN1 KIAA1549 IL1RAPL1 CRACD CCDC13 HSPA12A PTPRZ1	7.53e-06	185	171	7	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	CDK12 ARHGEF12 TRIM33 CRACD PRDM10 CEP295 SAP130	7.80e-06	186	171	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL9A1 PI16 MAMLD1 F5 HEG1 EFNB2 NAV1	8.66e-06	189	171	7	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL9A1 MUC13 F5 CRACD HEG1 EFNB2 NAV1	8.66e-06	189	171	7	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 PPFIBP1 ITGA10 ARHGEF12 IL1RAPL1 PCDH1 ADGRL3	9.27e-06	191	171	7	f229abf69a1217194f74b0502486907e07dba989
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF12 SNRK HEG1 EFNB2 RIPOR1 PCDH1 ADGRL3	9.59e-06	192	171	7	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNS2 HEG1 EFNB2 HMCN2 PTPRZ1 HEY2 IMPG2	9.92e-06	193	171	7	cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF12 SNRK HEG1 EFNB2 RIPOR1 PCDH1 ADGRL3	1.03e-05	194	171	7	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ARHGEF12 SNRK HEG1 EFNB2 NAV1 ADGRL3	1.03e-05	194	171	7	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ARHGEF12 GRB10 SNRK HEG1 EFNB2 ADGRL3	1.03e-05	194	171	7	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ARHGEF12 SNRK HEG1 EFNB2 NAV1 ADGRL3	1.03e-05	194	171	7	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PI16 ITGA10 F5 HMCN2 PTPRZ1 HEY2 LGI1	1.10e-05	196	171	7	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC37A3 RFX7 SBF2 SCAPER MAML2 UTY FBXW7	1.21e-05	199	171	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAT4 KIAA1549 DHX33 CNTLN WNK1 CELSR1 NAV1	1.21e-05	199	171	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	LPS_IL1RA\|World / Treatment groups by lineage, cell group, cell type	CYP1B1 ARHGEF12 SKIL HEG1 SRGAP1 PCDH1 ADGRL3	1.25e-05	200	171	7	a02fa5b3c4723a6eaa3c685588666c710478dd25
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	CYP1B1 ARSJ PI16 MAMLD1 SKIL F5 HEG1	1.25e-05	200	171	7	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAT4 ARHGEF12 SNRK HEG1 EFNB2 TNK2 ADGRL3	1.25e-05	200	171	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MFSD6 ARHGEF12 MUC16 CELSR1 FAT2 LLGL2 PTPRZ1	1.25e-05	200	171	7	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PI16 LRRC37A2 FAM13B CCDC13 LRRC37A PARP15	4.14e-05	164	171	6	1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	LRRC37A3 CAPS RNF13 KRBA1 KCNJ13 MAP2K7	4.14e-05	164	171	6	346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 GRB10 TNS2 IL1RAPL1 MAML2 ADGRL3	4.90e-05	169	171	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 FAT4 PRDM10 CSPG4 ASTN1 RECK	5.06e-05	170	171	6	50c6c571591aa4b218caefe5778c570c809f567e
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 FAT4 PRDM10 CSPG4 ASTN1 RECK	5.06e-05	170	171	6	8fe32dcf924d5f6665f7febbc9647d96b1e96f06
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 FAT4 PRDM10 CSPG4 ASTN1 RECK	5.06e-05	170	171	6	3232db50b1a40f861e981a1b9c9073b81af9f832
ToppCell	wk_20-22-Mesenchymal-Chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL9A1 ITGA10 COL24A1 PTPRZ1 CSPG4 RECK	5.23e-05	171	171	6	d2938639e9a7c349e5a6ec61724222f9d127c89f
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CAPS HEG1 USF3 SIK2 CEP295 MAML2	5.94e-05	175	171	6	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	LRRC37A3 DBF4B B4GALT1 COL24A1 LRRC37A PHLPP2	5.94e-05	175	171	6	29fbdfe1d3bfcb063be2bced0128a33176c5b78f
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL9A1 ITGA10 KIAA1549 ZNF385B COL24A1 CSPG4	6.13e-05	176	171	6	77c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL9A1 ACACB ITGA10 DNAH1 PTPRZ1 CSPG4	6.53e-05	178	171	6	a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA1549 DNAH1 CNNM3 USF3 CSPG4 HEY2	6.73e-05	179	171	6	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	POU2F1 TECPR2 MAP3K9 FCRL5 RECK PARP15	6.73e-05	179	171	6	5be883d7d0be3180bb9844e4a757f0dd247294e4
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAFA3 EFNB2 SRGAP1 HEY2 NAV1 MAML2	7.16e-05	181	171	6	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ARSJ KIAA1549 CCDC13 EFNB2 HEY2 HYDIN	7.61e-05	183	171	6	6f8f997ffc9eaebca2683de125b6069d07c07d26
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL1RAPL1 CCDC13 HSPA12A PTPRZ1 ADGRL3 LGI1	8.32e-05	186	171	6	adba5647a2feaba8e361dc1020d2f2dc4ce36b16
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP1B1 ARSJ PI16 MAMLD1 F5 EFNB2	8.32e-05	186	171	6	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HCN1 MUC16 CNTLN SRGAP1 NAV1 ASTN1	8.32e-05	186	171	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HCN1 IL1RAPL1 CCDC13 HSPA12A PTPRZ1 ADGRL3	8.82e-05	188	171	6	c2101ded71fb16b8ddbc1f883911b1ed2a533ffc
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CYP1B1 PI16 FREM1 IL1RAPL1 HMCN2 ADGRL3	8.82e-05	188	171	6	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HCN1 IL1RAPL1 CCDC13 HSPA12A PTPRZ1 ADGRL3	8.82e-05	188	171	6	3b8b9161f0fdcbde302ce5b4c0bc874628211109
ToppCell	Non-neuronal-Non-dividing-OPC-OPC\|World / Primary Cells by Cluster	COL9A1 RNF13 PTPRZ1 CSPG4 TNK2 MAML2	9.09e-05	189	171	6	ddf5be73912570c32c50f4ac2902da9b590526f8
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	CDC42BPA ACACB SNRK FREM1 MAML2 UTY	9.09e-05	189	171	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Non-neuronal-Non-dividing-OPC\|World / Primary Cells by Cluster	COL9A1 RNF13 PTPRZ1 CSPG4 TNK2 MAML2	9.09e-05	189	171	6	13848a031ab896b4b24c8319e4745b9b17ff9cfd
ToppCell	Non-neuronal-Non-dividing-OPC-OPC-30\|World / Primary Cells by Cluster	COL9A1 RNF13 PTPRZ1 CSPG4 TNK2 MAML2	9.09e-05	189	171	6	313d165fad541ec6e8dd524b88856e2c93eeb681
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PIGN ACACB FCHO2 DNAH1 BAZ2A CD33	9.35e-05	190	171	6	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	Fibroblasts-CD55+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MFSD6 CAPS ZNF385B F5 HSPA12A EFNB2	9.35e-05	190	171	6	b4088128f5acf53f43244c9af9fe44e033f1a57a
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 PPFIBP1 ITGA10 ARHGEF12 PCDH1 ADGRL3	9.35e-05	190	171	6	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL9A1 PTPRZ1 CSPG4 NAV1 TNK2 ADGRL3	9.35e-05	190	171	6	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGEF12 SNRK HEG1 NAV1 ADGRL3 SON	9.35e-05	190	171	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	RICTOR SETD2 BAZ2A ARHGEF7 ELF1 PARP15	9.63e-05	191	171	6	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	DIP2A SIGLEC7 SBF2 SUPT7L PHLPP2 PARP15	9.63e-05	191	171	6	2b427741a58921e161101a282d1fe526cd9e760d
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 ACACB LRRC37A3 HEG1 NAV1 UTY	9.91e-05	192	171	6	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	Fibroblasts-CD55+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	CAPS ZNF385B F5 HSPA12A EFNB2 CSPG4	1.02e-04	193	171	6	8f4bf9a2fbedae35432dad96730b00c70185874c
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ARHGEF12 SNRK HEG1 EFNB2 ADGRL3	1.02e-04	193	171	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 GRB10 SNRK HEG1 EFNB2 ADGRL3	1.02e-04	193	171	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	IPF-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	FAT4 PPFIBP1 ITGA10 ARHGEF12 EFNB2 PCDH1	1.02e-04	193	171	6	d7750a7575ef257963b7f1c64fa67c52dbff797b
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 GRB10 EFNB2 SBF2 NAV1 ADGRL3	1.02e-04	193	171	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ARHGEF12 SNRK HEG1 EFNB2 ADGRL3	1.02e-04	193	171	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	PND10-Endothelial-Endothelial_blood-vessel\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGEF12 SNRK HEG1 EFNB2 NAV1 PCDH1	1.02e-04	193	171	6	1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486
ToppCell	PND10-Endothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGEF12 SNRK HEG1 EFNB2 NAV1 PCDH1	1.02e-04	193	171	6	f3c743b340fc588bc8effd375b12e2c7cbfa49d2
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDK12 GRB10 SNRK FCHO2 NIPBL SON	1.05e-04	194	171	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	IPF-Endothelial-VE_Capillary_B\|IPF / Disease state, Lineage and Cell class	PPFIBP1 ITGA10 ARHGEF12 HEG1 EFNB2 PCDH1	1.05e-04	194	171	6	169a304d5c13f08c39fad4116f093bc4a0765e9d
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	CYP1B1 ARSJ PI16 HMCN2 SRGAP1 MAML2	1.05e-04	194	171	6	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 SNRK HEG1 EFNB2 NAV1 ADGRL3	1.05e-04	194	171	6	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 SNRK HEG1 EFNB2 NAV1 ADGRL3	1.05e-04	194	171	6	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP1B1 DBF4B APBA3 SNRK B4GALT1 RIPOR1	1.08e-04	195	171	6	6a0460d949ccda7c9fe76870d3ee6c2f60677d61
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRB10 SNRK EFNB2 NAV1 RIPOR1 ADGRL3	1.08e-04	195	171	6	56efeb58df19f357d7d5ce87348d4f196a595421
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYP1B1 MUC16 F5 HMCN2 MUC3A LGI1	1.08e-04	195	171	6	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYP1B1 MUC16 F5 HMCN2 MUC3A LGI1	1.08e-04	195	171	6	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC37A3 ZNF385B RFX7 SCAPER MAML2 FBXW7	1.11e-04	196	171	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDC42BPA PPFIBP1 GRB10 HEG1 EFNB2 NAV1	1.11e-04	196	171	6	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL9A1 PTPRZ1 CSPG4 NAV1 TNK2 ADGRL3	1.11e-04	196	171	6	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL9A1 PTPRZ1 CSPG4 NAV1 TNK2 ADGRL3	1.11e-04	196	171	6	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FAT4 FREM1 IL1RAPL1 COL24A1 SBF2 MAML2	1.11e-04	196	171	6	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL9A1 CDC42BPA ITGA10 KIAA1549 ZNF385B CSPG4	1.14e-04	197	171	6	4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL9A1 CDC42BPA ITGA10 KIAA1549 ZNF385B CSPG4	1.14e-04	197	171	6	ece0c17eb68f394b20e588c0b0626d3987a4dbbb
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 PPFIBP1 SNRK HEG1 EFNB2 ADGRL3	1.17e-04	198	171	6	d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCell	facs-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL9A1 CDC42BPA ITGA10 KIAA1549 ZNF385B CSPG4	1.17e-04	198	171	6	71e847e8c24744d6df4a960348ad2ecf310373b4
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMTF1 RICTOR DIP2A ATF7IP UTY PARP15	1.20e-04	199	171	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL9A1 MAMLD1 CSPG4 NAV1 TNK2 ASTN1	1.20e-04	199	171	6	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL9A1 CSPG4 NAV1 TNK2 ASTN1 HYDIN	1.20e-04	199	171	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL9A1 MAMLD1 CSPG4 NAV1 TNK2 ASTN1	1.20e-04	199	171	6	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYP1B1 FAT4 CDC42BPA HEG1 EFNB2 PCDH1	1.20e-04	199	171	6	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MFSD6 ARHGEF12 CELSR1 FAT2 LLGL2 PTPRZ1	1.24e-04	200	171	6	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PI16 MAMLD1 SKIL F5 HEG1 EFNB2	1.24e-04	200	171	6	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	ACACB LRRC37A2 RFX7 B4GALT1 LLGL2 PCDH1	1.24e-04	200	171	6	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 PI16 MAMLD1 F5 HEG1 EFNB2	1.24e-04	200	171	6	ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL9A1 MAMLD1 CSPG4 NAV1 TNK2 ASTN1	1.24e-04	200	171	6	ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	CAPS F5 CCDC13 KCNJ13 HYDIN PDE11A	1.24e-04	200	171	6	177f9ad8dd8635394c575a2b30140184df0bd51e
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	GRB10 POU2F1 TSC22D2 SKIL EFNB2 ATF7IP NIPBL SON FBXW7	6.04e-06	174	168	9	1302_UP
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; PC3; HT_HG-U133A	ZBTB33 CDC42BPA MFHAS1 SNRK B4GALT1 TRIM33 KCNJ13 GMEB1 MAP2K7	1.45e-05	194	168	9	4624_UP
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A	CDC42BPA PRR36 B4GALT1 BAZ2A SCAPER MAP2K7 PCDH1 UTY IMPG2	1.45e-05	194	168	9	3245_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	ACACB MAMLD1 SNRK TTBK2 DIP2A GTF2I SUPT7L BICRAL NIPBL	1.45e-05	194	168	9	4662_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; HL60; HT_HG-U133A	ACACB CNTLN F5 CHMP7 CNNM3 CELSR1 BAZ2A UTY ADGRL3	1.51e-05	195	168	9	2470_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; PC3; HT_HG-U133A	ARSJ CDC42BPA MFSD6 EYA3 TECPR2 ARHGEF7 RIPOR1 RECK FBXW7	1.64e-05	197	168	9	4091_DN
Drug	Milrinone [78415-72-2]; Up 200; 19uM; MCF7; HT_HG-U133A	WNK1 F5 TTBK2 SIGLEC7 KCNJ13 SCAPER SIK2 SLC24A1 MAP2K7	1.70e-05	198	168	9	7210_UP
Drug	BAS 012416453; Down 200; 38uM; MCF7; HT_HG-U133A	CYP1B1 DBF4B GRB10 TSC22D2 BFSP1 GMEB1 HEY2 TNK2 SLC24A1	1.70e-05	198	168	9	6880_DN
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	CYP1B1 POU2F1 TSC22D2 SKIL EFNB2 BAZ2A ATF7IP SON	3.06e-05	164	168	8	3852_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	CDK12 TRIM33 SETD2 ARHGEF7 ATF7IP ELF1 SAP130 NIPBL	6.65e-05	183	168	8	7498_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	TSC22D2 CCNF TRIM33 EFNB2 ATF7IP ELF1 NIPBL PHLPP2	6.91e-05	184	168	8	2321_DN
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A	RC3H2 ARHGEF12 GRB10 WNK1 SETD2 MAP3K9 ELF1 SON	8.65e-05	190	168	8	7070_UP
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	FAT4 CDC42BPA ACACB MFSD6 ARHGEF12 RFX7 BFSP1 SETD2	9.31e-05	192	168	8	1792_UP
Drug	Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; HL60; HG-U133A	ARHGEF12 TSC22D2 SKIL TTBK2 SETD2 BAZ2A SCAPER SIK2	1.00e-04	194	168	8	1364_UP
Drug	Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	CYP1B1 DBF4B SNRK SKIL WNK1 TRIM33 BAZ2A SCAPER	1.00e-04	194	168	8	4470_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	RC3H2 CDC42BPA DBF4B SKIL WNK1 EFNB2 ELF1 SLC24A1	1.00e-04	194	168	8	4312_DN
Drug	Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A	PIGN FAT4 CDC42BPA ACACB SKIL TECPR2 TNK2 PCDH1	1.00e-04	194	168	8	3284_UP
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A	CYP1B1 ACACB SKIL F5 B4GALT1 PRDM10 SIGLEC7 ARHGEF7	1.04e-04	195	168	8	1156_UP
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CYP1B1 GRB10 TSC22D2 HSPA12A BAZ2A SCAPER RIPOR1 PDE11A	1.07e-04	196	168	8	7409_UP
Drug	Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; HL60; HT_HG-U133A	CDC42BPA ACACB APBA3 TNS2 TRIM33 SIGLEC7 SUPT7L TNK2	1.07e-04	196	168	8	1849_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A	CLIP2 WNK1 TRIM33 CELSR1 HEG1 SIGLEC7 SCAPER TNK2	1.07e-04	196	168	8	2951_UP
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	CDC42BPA ACACB MFSD6 EYA3 F5 HEG1 TNK2 ASTN1	1.07e-04	196	168	8	6169_UP
Drug	Miconazole [22916-47-8]; Up 200; 9.6uM; HL60; HG-U133A	CDK12 MPDU1 SNRK TSC22D2 TRIM33 ARHGEF7 DNASE1L1 RECK	1.11e-04	197	168	8	1977_UP
Drug	Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A	HNF1A CDC42BPA ACACB SIGLEC7 TNK2 SLC24A1 MAP2K7 RECK	1.11e-04	197	168	8	3390_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; HL60; HT_HG-U133A	RC3H2 DBF4B MPDU1 SRR SCAPER GMEB1 MAP2K7 UTY	1.11e-04	197	168	8	2350_DN
Drug	Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A	PIGN MFHAS1 PPFIBP1 SRR WNK1 DIP2A SUPT7L HEY2	1.11e-04	197	168	8	3485_UP
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A	CYP1B1 RC3H2 ACACB ARHGEF12 CHMP7 BAZ2A RIPOR1 RECK	1.11e-04	197	168	8	5865_DN
Drug	Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	ACACB PRR36 ITGA10 TMEM104 TTBK2 SUPT7L SCAPER SIK2	1.11e-04	197	168	8	3202_DN
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A	HNF1A CDC42BPA TNS2 MUC13 TSC22D2 SCAPER TNK2 IMPG2	1.15e-04	198	168	8	3842_UP
Drug	Piretanide [55837-27-9]; Down 200; 11uM; HL60; HT_HG-U133A	CLIP2 TNS2 EYA3 SKIL LLGL2 ARHGEF7 RIPOR1 ADGRL3	1.15e-04	198	168	8	6144_DN
Drug	Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A	ACACB PRR36 ARHGEF12 PRDM10 SIGLEC7 MAP2K7 PCDH1 PHLPP2	1.15e-04	198	168	8	5614_UP
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ZBTB33 ACACB ARHGEF12 SIGLEC7 BAZ2A MAP3K9 HEY2 SLC24A1	1.15e-04	198	168	8	2845_UP
Drug	Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; HL60; HT_HG-U133A	RC3H2 SNRK SRR SKIL LRCH3 RIPOR1 UTY DNASE1L1	1.15e-04	198	168	8	1330_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A	RC3H2 DBF4B SKIL TRIM33 TTBK2 BAZ2A NIPBL PHLPP2	1.15e-04	198	168	8	2362_DN
Drug	Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PRR36 APBA3 SIK2 RIPOR1 MUC6 UTY PDE11A FBXW7	1.15e-04	198	168	8	7357_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A	GRB10 SNRK TSC22D2 SCAPER GMEB1 SIK2 MAP2K7 MUC6	1.19e-04	199	168	8	7172_UP
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	PRR36 EYA3 BFSP1 HSPA12A TECPR2 BAZ2A SCAPER FBXW7	1.19e-04	199	168	8	4691_DN
Drug	tamoxifen citrate; Down 200; 1uM; MCF7; HG-U133A	PPFIBP1 ARHGEF12 TSC22D2 WNK1 DENND4C CCNF BAZ2A UTY	1.19e-04	199	168	8	380_DN
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; PC3; HT_HG-U133A	RC3H2 SNRK HSPA12A HEG1 CSPG4 PCDH1 MUC6 PDE11A	1.23e-04	200	168	8	4638_UP
Disease	azoospermia (implicated_via_orthology)	CDC42BPA DMRT2 SCAPER	4.31e-04	27	162	3	DOID:14227 (implicated_via_orthology)
Disease	varicose veins (is_marker_for)	EFNB2 HEY2	4.43e-04	6	162	2	DOID:799 (is_marker_for)
Disease	uric acid measurement	PIGN HNF1A FAT4 CDC42BPA GRB10 F5 B4GALT1 TMEM11 SBF2 SIK2 NAV1	5.79e-04	610	162	11	EFO_0004761
Disease	smoking status measurement, high density lipoprotein cholesterol measurement	EYA3 PTPRZ1	6.18e-04	7	162	2	EFO_0004612, EFO_0006527
Disease	severe acute respiratory syndrome, COVID-19	MAMLD1 GRB10 TG IL1RAPL1 COL24A1 HSPA12A ARHGEF7 MAML2 ADGRL3	8.53e-04	447	162	9	EFO_0000694, MONDO_0100096
Disease	Adenocarcinoma of lung (disorder)	PIGN SRR WNK1 TRIM33 TNK2 DOT1L	9.98e-04	206	162	6	C0152013
Disease	Disorder of eye	CYP1B1 COL9A1 FREM1 KCNJ13 SLC24A1 IMPG2	1.16e-03	212	162	6	C0015397
Disease	Congenital disorder of glycosylation	MPDU1 B4GALT1 ALG8	1.19e-03	38	162	3	cv:C0282577
Disease	Cystic Kidney Diseases	FAT4 ALG8	1.59e-03	11	162	2	C1691228
Disease	schizophrenia, type 2 diabetes mellitus	HNF1A CDK12 HCN1	1.71e-03	43	162	3	MONDO_0005090, MONDO_0005148
Disease	optic disc area measurement	ARSJ CDC42BPA F5	1.95e-03	45	162	3	EFO_0006937
Disease	heart rate variability measurement, response to antipsychotic drug	RICTOR SKIL SAP130	2.07e-03	46	162	3	EFO_0008003, GO_0097332
Disease	T-cell surface glycoprotein CD3 epsilon chain measurement	F5 PIKFYVE	2.25e-03	13	162	2	EFO_0802114
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	FAT4 LGI1	2.61e-03	14	162	2	EFO_0004670, EFO_0006794
Disease	Williams-Beuren syndrome (implicated_via_orthology)	CLIP2 GTF2I	3.00e-03	15	162	2	DOID:1928 (implicated_via_orthology)
Disease	myeloid cell surface antigen CD33 measurement	SIGLEC7 CD33	3.00e-03	15	162	2	EFO_0008238
Disease	red blood cell density measurement	HNF1A ARSJ CDK12 RICTOR FCHO2 RFX7 WNK1 B4GALT1 TG TRIM33 SBF2 MAML2	3.50e-03	880	162	12	EFO_0007978
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 SETD2	3.86e-03	17	162	2	DOID:0060307 (is_implicated_in)
Disease	chronic lymphocytic leukemia	ARSJ RFX7 FREM1 KPNA7	4.26e-03	119	162	4	EFO_0000095
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC3A MUC6	5.30e-03	64	162	3	DOID:4947 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
TEVPSILAAHSLPSL	PI16	286	Q6UXB8
ASNLTSVPVPHTTAL	B4GALT1	111	P15291
HSSISPVRLPLNSSL	CDK12	381	Q9NYV4
SSQLVAHPPGTVITS	ELF1	541	P32519
HLPLATVSPGTTQLT	CAPS	51	Q13938
LQTPAETLLSDSIPH	CSPG4	96	Q6UVK1
AQVPHRPSLSSLETL	CNTLN	446	Q9NXG0
SSTIQLHPATSPAVS	BAZ2A	416	Q9UIF9
ELALSPIHNSSALPT	MASTL	366	Q96GX5
IGNITLSPAISRHSP	FCHO2	381	Q0JRZ9
NPPLSSQATVHITVT	FAT4	3066	Q6V0I7
TTHLPSASSQIPALE	ADGRL3	481	Q9HAR2
TSVTLSIVHCPPVTT	APBA3	471	O96018
LHSGTATPPLTSRVI	CLIP2	171	Q9UDT6
QPPQHLVTTILLSAS	ARHGEF7	91	Q14155
LSSTTVLFRPIHPIN	CELSR1	1331	Q9NYQ6
ATVGSRSSTPQHPLL	DOT1L	976	Q8TEK3
LPLTLTASPTVTLTA	DMTF1	521	Q9Y222
SVLPLTTLTDPILQH	DMTF1	716	Q9Y222
QPVLRLSTVHEPSST	ASTN1	1031	O14525
LLSVELSTSRPPQHL	TNK2	496	Q07912
QSLVGSPSTRIAPHI	ARHGEF12	336	Q9NZN5
HTQKAPLVSSTLPVA	RC3H2	786	Q9HBD1
DSPTLASHVPLSALI	RECK	916	O95980
SGLIQTPSPSQHSVL	EYA3	131	Q99504
TTTVDSIQAPIPSHT	PTPN23	881	Q9H3S7
ATSPLTTVHTTPILT	KIAA1549	786	Q9HCM3
EIVLTQSPATLSLSP	IGKV3D-11	21	A0A0A0MRZ8
TVPISITNPDLLRHS	ACACB	1336	O00763
PPLSTSLLSLSATVH	HEY2	251	Q9UBP5
SLVPIHATTSPSNIL	MUC16	4161	Q8WXI7
SPLPVTALLTSVLVT	MUC16	5656	Q8WXI7
SPPNLSSTSHEILTT	MUC16	6856	Q8WXI7
TVSLVTHPAQTSPTV	MUC16	10821	Q8WXI7
TTLPTHVPPFSTSLV	MUC6	1441	Q6W4X9
TLPTHVPPFSTSLVT	MUC6	1611	Q6W4X9
PITTQLPHLSSATTP	MUC6	2106	Q6W4X9
TLPHTISSPFTLSAL	MUC6	2211	Q6W4X9
LVESVVQTPSTLHLP	OR2H2	151	O95918
SSSTRPITSPLQEVH	PARP15	231	Q460N3
TSNAIPHLLALISPT	KPNA7	196	A9QM74
QTLHRSLTEVTGPPT	LRRC37A3	781	O60309
APTRSLHLVSPQVFT	KRBA1	561	A5PL33
RPNALLSSPATETVH	LRCH3	576	Q96II8
APSATQITVVLPHSS	LLGL2	126	Q6P1M3
QTLHRSLTEVTGPPT	LRRC37A2	781	A6NM11
QTLHRSLTEVTGPPT	LRRC37A	781	A6NMS7
EIVLTQSPATLSLSP	IGKV3D-20	21	A0A0C4DH25
TPQGTVLLHTPATSE	SLC24A1	306	O60721
TLSQGSSPVTVHTLP	GMEB1	426	Q9Y692
LQPDTLSIASHASLP	MFHAS1	936	Q9Y4C4
KLLVSSAPTHLTPNI	ZBTB33	266	Q86T24
TPLHDSLPITGTSVA	SBF2	186	Q86WG5
HTTILQVSIPSLLPA	PPFIBP1	401	Q86W92
PLTNITAALHSPLTL	HMCN2	2366	Q8NDA2
LEPSTTSTSQPHLIF	ARSJ	66	Q5FYB0
TTHSSVLIITPRPQD	CD33	191	P20138
IPTVHTSPQLINTTA	KIAA2026	1976	Q5HYC2
ATSTHISPISILPAS	FAM13B	281	Q9NYF5
SLLPVLKSSHQTPTL	FAM90A27P	206	A6NNH2
SSPLHLESVLSILAP	MBD3L5	106	A6NJ08
PQHTTTLSLSTLATP	EFNB2	261	P52799
SGIPPLSSLTSVRVH	FAT2	3506	Q9NYQ8
LSVTVPVSHPVLNLS	FCRL5	371	Q96RD9
VTVPVSHPVLTLSSA	FCRL5	466	Q96RD9
HTNSAILPLLPRETS	IL1RAPL1	676	Q9NZN1
TESPRTSGVLSQPHL	MAP2K7	401	O14733
TAPSNTSHKLLTPQT	PCDH1	716	Q08174
SPHDTLISETLLNSP	MUC3A	81	Q02505
PTSFIITISHPTSIC	MUC3A	131	Q02505
HTQSISSPPAITSTL	MUC3A	1676	Q02505
SIPTDISTLPTRTHI	MUC3A	2511	Q02505
ASSLPPTTAHILSAL	PDE11A	161	Q9HCR9
LSVTPQRTTGALHTP	DDIAS	461	Q8IXT1
TAPRITLLHSPSQVG	FREM1	1626	Q5H8C1
SSPLHLESVLSILAP	MBD3L2B	106	A0A1B0GVZ6
PHVPITTLAGIASLT	NIPBL	6	Q6KC79
SITPSSPLATLLQHE	KCNJ13	246	O60928
SHITTANLPPQISSI	EP400P1	246	Q6ZTU2
LVTVSTPLHQVSPTG	HNF1A	341	P20823
LSLTHPEILVPQIST	HEG1	881	Q9ULI3
TGITPLSPSHIVNDT	HSPA12A	31	O43301
TIHTPLTTAVISATP	PRDM10	866	Q9NQV6
ISLTSQTVTELPPHT	PTPRZ1	516	P23471
LITPTASLLQPTHAL	PTPRZ1	976	P23471
TTHPTNASHQLTILP	MFSD6	166	Q6ZSS7
HLSLSKSNSVSLVPP	RICTOR	1276	Q6R327
SSPLHLESVLSILAP	MBD3L3	106	A6NE82
LTVSPVLPLTSAAVT	POU2F1	476	P14859
DLHISSTPAATTLPV	PROSER1	591	Q86XN7
ALANPVSTHTILTPN	MAML2	831	Q8IZL2
THLPTPSSTLQEQLT	NPAS4	446	Q8IUM7
IHPDSSNTPLSTRLV	PIKFYVE	276	Q9Y2I7
ATITSQLLPTPAKSH	DNAH1	2421	Q9P2D7
VSLPISVHTQTFLPS	ATMIN	451	O43313
LSASQPSLPHEVSTL	HCN1	786	O60741
ISPSSTIHIPLVLET	HYDIN	756	Q4G0P3
PTVLHLSPGQSSVSQ	BICRAL	506	Q6AI39
VSRPVLSPTHINATA	CCDC150	11	Q8NCX0
SNVLPSLVLVPLHTT	DNASE1L1	136	P49184
SLVLPHTPEIQTTRS	DMRT2	401	Q9Y5R5
LPQPTSVLSLDSDSH	CCNF	721	P41002
SHTCVSATTLLPALP	DBF4B	421	Q8NFT6
PLSSHPVVALSELST	CHMP7	171	Q8WUX9
SLPASSLARHVLPTT	CRTC2	371	Q53ET0
LTCLNSITHLPLTTV	SLC49A4	366	Q96SL1
QQIIHTTPPASIVTS	BFSP1	191	Q12934
PSSLSVPHTAILVTG	CRACD	586	Q6ZU35
HTLVESALTRPSLPS	CCDC13	511	Q8IYE1
SSSIVDLPVHQLSSP	FBXW7	146	Q969H0
TLSQVHSPLVTSPSA	BCL9L	936	Q86UU0
VSLLSVDSVLHNPPS	DHX33	526	Q9H6R0
SVHDALILSQPVSTP	DENND4C	371	Q5VZ89
PTAHSIVQATRTSLP	ATF7IP	876	Q6VMQ6
TIHLLPTAPTTVNVT	ATF7IP	1026	Q6VMQ6
EPLVLDHPQATLSTT	MAMLD1	206	Q13495
STSPVVPASLHGLLS	IFRD2	286	Q12894
SSRPIVHLTPSLEVT	ITGA10	641	O75578
VHLTPSLEVTPQAIS	ITGA10	646	O75578
ILGSQSPLHPSTLST	GRB10	471	Q13322
EIVLTQSPATLSLSP	IGKV3-11	21	P04433
HIPLTSIDLCPTSVS	KRTAP26-1	21	Q6PEX3
VTSPKILHSPNSQAL	CEP57L1	41	Q8IYX8
TCHELPARITPSQTT	COL9A1	251	P20849
PVTIPHATTANTSVL	CYP1B1	396	Q16678
RLTSTPLQSHSSVEP	DIP2A	151	Q14689
QVTSVLSRLSLFPHP	FHIP2A	656	Q5W0V3
PELLTHSTTEVTQPR	GTF2I	541	P78347
TLPITTVAQSSVLLH	CEP295	481	Q9C0D2
HVIPSPSTDRINVTS	SCAPER	181	Q9BY12
DPNQSLTPTHVTLTT	MAP3K9	891	P80192
SSPLHLESVLSILAP	MBD3L4	106	A6NDZ8
SSPLHLESVLSILAP	MBD3L2	106	Q8NHZ7
VTASLLAIPHTPESS	OTOG	1566	Q6ZRI0
EGTTPLTSIPVSHTL	MUC17	2276	Q685J3
PVAVTSPITHTAQSA	NAV1	536	Q8NEY1
HLTLAALQPPTATVL	TAFA3	26	Q7Z5A8
DLPLASHRSTSQILP	UTY	816	O14607
LLTALPNHSSSPETT	TRMT13	466	Q9NUP7
ESSLTPPLSTNLHLE	TRIM33	811	Q9UPN9
PAVINAHVSTISLPT	PRSS3P2	116	Q8NHM4
TPATSTESLSPLHNV	SRGAP1	1001	Q7Z6B7
RSLATVHPDSSNLIP	SFXN4	91	Q6P4A7
RTCTSVPETLHLNPS	SKIL	71	P12757
PVSRSSSIIQHVGLP	TSC22D2	546	O75157
QTNLSPDLSHTTLSP	F5	1201	P12259
PDLSHTTLSPELIQR	F5	1206	P12259
TPHSSSLTCQLATPL	PRR36	356	Q9H6K5
SPLTIHPLQALSSLA	PRR36	681	Q9H6K5
TEHTPLLRPLASVSA	RNF13	306	O43567
FSHIQTPVVSSTPRL	MRPL35	46	Q9NZE8
PLHPSTTRSSVLTLI	SIGLEC7	191	Q9Y286
TTRSSVLTLIPQPQH	SIGLEC7	196	Q9Y286
ESVSTLPASVHPQLS	SIK2	656	Q9H0K1
PSEPCSLTIHTIQLI	SUPT7L	56	O94864
DSIHLTPVLTSSILN	SRR	21	Q9GZT4
VSSLTLHSVTPAVLQ	IMPG2	481	Q9BZV3
RTVDSTPLSVHTPTL	CDC42BPA	981	Q5VT25
DLTATPLSHATVPQS	SNRK	376	Q9NRH2
SPLTPLTVVTLLQAS	MPDU1	146	O75352
STSSTHTPLPVFRLL	SLC23A3	251	Q6PIS1
LTVSRLAPSHQASPL	SARDH	621	Q9UL12
HTVLPSVTPLATLIC	ALG8	326	Q9BVK2
TVPSSVHQSPVSSLQ	CNNM3	591	Q8NE01
SASTPLPQGVHLTES	COL24A1	66	Q17RW2
VLLPHPLRSTESTNA	TEX22	111	C9J3V5
LPLHTLTSSTPVVLV	TMEM11	146	P17152
APPIISTHSSSTIPI	MUC13	86	Q9H3R2
PHISSTPLTIQDELL	PHLPP2	966	Q6ZVD8
AVSHLRLLPTANSPS	ST20-AS1	21	Q8NBB2
VTTRITLPSHPALGT	SAP130	341	Q9H0E3
TSTTPQLHTRLTPAA	TTBK2	311	Q6IQ55
CQHSLPSLITPVSSK	TMEM104	286	Q8NE00
PHILVSQVPGLSSTT	USF3	951	Q68DE3
EVPLLNSLTVPSSLS	TECPR2	641	O15040
ISLTPSNSNTPLKHS	RFX7	381	Q2KHR2
STCHTTTLPALVRTP	ZNF385B	86	Q569K4
TLASSLVVPLLSSPV	PIGN	691	O95427
IAQPTILTTTATLPA	SAP30BP	266	Q9UHR5
LLATTTAVASPPTHA	SETD2	156	Q9BYW2
PHLLTIQPDLSTTTT	UNC5A	361	Q6ZN44
VSQIPISTPHVSTAQ	WNK1	841	Q9H4A3
TSSSIPPIILLQFLH	USP14	166	P54578
TSPTHPTTSPILINV	RIPOR1	666	Q6ZS17
ASVPSVPISTHGRLL	TG	2196	P01266
TLLLSIPVTSAHPGV	VIRMA	686	Q69YN4
STSLLVPAVTTPVLA	SON	1326	P18583
SALVSQHSISPISLP	TNS2	1226	Q63HR2
TVTPALSSNVLPRHL	LNPK	211	Q9C0E8
PQTLRTPHLILSSSS	LGI1	391	O95970
TPHLILSSSSQRPVI	LGI1	396	O95970